Sponsored
Sponsored
-
Sponsored by Norton Rose FulbrightBeijing-based Norton Rose Fulbright partner Barbara Li explains what China’s new foreign direct investment rules mean for foreign companies entering one of the world’s biggest marketplaces -
Sponsored by Stikeman ElliottStikeman Elliott partners analyse Canada’s new takeover bid regime and its impact on Aurora’s recent hostile bid for competitor CanniMed
-
Sponsored by Baker McKenzieBaker McKenzie lawyers review the global biotech IPO landscape, considering how regulatory initiatives have aided growth
